These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 29432993

  • 21. Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway.
    Liu W, Huang G, Yang Y, Gao R, Zhang S, Kou B.
    Int J Med Sci; 2021; 18(1):81-87. PubMed ID: 33390776
    [Abstract] [Full Text] [Related]

  • 22. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
    Wang YY, Lv YF, Lu L, Cai L.
    Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
    [Abstract] [Full Text] [Related]

  • 23. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J, Jiang H, Wang C, Yang B, Zhao L, Hu D, Qiu G, Dong X, Xiao B.
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [Abstract] [Full Text] [Related]

  • 24. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT, Zhong W, Sun P, Wang D, Wang C, Hu LM, Qian JQ.
    J Ethnopharmacol; 2017 Mar 22; 200():107-116. PubMed ID: 28088493
    [Abstract] [Full Text] [Related]

  • 25. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
    Chen K, Ye J, Qi L, Liao Y, Li R, Song S, Zhou C, Feng R, Zhai W.
    Anticancer Drugs; 2019 Oct 22; 30(9):925-932. PubMed ID: 31517732
    [Abstract] [Full Text] [Related]

  • 26. Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.
    Li D, Wu LJ, Tashiro S, Onodera S, Ikejima T.
    J Asian Nat Prod Res; 2008 Oct 22; 10(1-2):77-87. PubMed ID: 18058384
    [Abstract] [Full Text] [Related]

  • 27. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS, Gan CP, Lau BF, Yee PS, Tiong KH, Abdul Rahman ZA, Patel V, Cheong SC.
    Phytomedicine; 2018 Jan 15; 39():33-41. PubMed ID: 29433681
    [Abstract] [Full Text] [Related]

  • 28. Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation.
    Zheng M, Zhu Z, Zhao Y, Yao D, Wu M, Sun G.
    Mol Med Rep; 2017 Jan 15; 15(1):375-379. PubMed ID: 27959435
    [Abstract] [Full Text] [Related]

  • 29. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
    Qiu Y, Li C, Wang Q, Zeng X, Ji P.
    Cancer Med; 2018 Feb 15; 7(2):397-407. PubMed ID: 29316373
    [Abstract] [Full Text] [Related]

  • 30. The cell death of C6 astrocytoma cells induced by oridonin and its mechanism.
    Yin B, Sheng H, Lin J, Zhou H, Zhang N.
    Int J Clin Exp Pathol; 2012 Feb 15; 5(6):562-8. PubMed ID: 22949939
    [Abstract] [Full Text] [Related]

  • 31. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S, Ikejima T.
    Arch Biochem Biophys; 2009 Oct 01; 490(1):70-5. PubMed ID: 19699177
    [Abstract] [Full Text] [Related]

  • 32. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S, Cui Z, Yan T, Wu J, Liu Z.
    Cell Biol Int; 2020 Apr 01; 44(4):998-1008. PubMed ID: 31889370
    [Abstract] [Full Text] [Related]

  • 33. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S, Gao J, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z.
    Int J Oncol; 2005 Mar 01; 26(3):579-88. PubMed ID: 15703811
    [Abstract] [Full Text] [Related]

  • 34. Oridonin inhibits tumor growth in glioma by inducing cell cycle arrest and apoptosis.
    Zhang XH, Liu YX, Jia M, Han JS, Zhao M, Ji SP, Li AM.
    Cell Mol Biol (Noisy-le-grand); 2014 Dec 30; 60(6):29-36. PubMed ID: 25553351
    [Abstract] [Full Text] [Related]

  • 35. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells.
    Zhang D, Zhou Q, Huang D, He L, Zhang H, Hu B, Peng H, Ren D.
    Biochem Biophys Res Commun; 2019 Jun 04; 513(3):594-601. PubMed ID: 30981511
    [Abstract] [Full Text] [Related]

  • 36. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
    Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM.
    Biochem Biophys Res Commun; 2005 Nov 11; 337(1):224-31. PubMed ID: 16176802
    [Abstract] [Full Text] [Related]

  • 37. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2/M phase arrest via PI3K/AKT signaling pathway.
    Li K, You G, Jiang K, Wang R, Li W, Meng Y, Fang Y, Chen W, Zhu G, Song J, Wang W, Su H, Hu B, Sun F, Jia Z, Li C, Zhu J.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):117014. PubMed ID: 37557938
    [Abstract] [Full Text] [Related]

  • 38. Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells.
    Jin S, Shen JN, Wang J, Huang G, Zhou JG.
    Cancer Biol Ther; 2007 Feb 10; 6(2):261-8. PubMed ID: 17218775
    [Abstract] [Full Text] [Related]

  • 39. Augmentation of oridonin-induced apoptosis observed with reduced autophagy.
    Cui Q, Tashiro S, Onodera S, Ikejima T.
    J Pharmacol Sci; 2006 Jul 10; 101(3):230-9. PubMed ID: 16861822
    [Abstract] [Full Text] [Related]

  • 40. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
    Wang HY, Zhang Y, Zhou Y, Lu YY, Wang WF, Xin M, Guo XL.
    Biomed Pharmacother; 2016 Oct 10; 83():349-361. PubMed ID: 27416556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.